Taking T-Cell Oncotheraphy Off-the-Shelf

被引：15
|
作者：
Mo, Feiyan [1 ,2 ,3 ]
Mamonkin, Maksim [1 ,2 ,3 ,4 ,5 ]
Brenner, Malcolm K. [1 ,2 ,3 ,5 ]
Heslop, Helen E. [1 ,2 ,3 ,5 ]
机构：
[1] Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA
[2] Houston Methodist Hosp, Houston, TX 77030 USA
[3] Baylor Coll Med, Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA
来源：
TRENDS IN IMMUNOLOGY | 2021年 / 42卷 / 03期
关键词：
CHIMERIC-ANTIGEN-RECEPTOR; MINOR HISTOCOMPATIBILITY ANTIGENS; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; NK CELLS; IMMUNOTHERAPY; CAR; EXPRESSION; PLATFORM; TUMOR;
D O I：
10.1016/j.it.2021.01.004
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Banked allogeneic or 'off-the-shelf' (OTS) T cells from healthy human donors are being developed to address the limitations of autologous cell therapies. Potential challenges of OTS T cell therapies are associated with their allogeneic origin and the possibility of graft-versus-host disease (GvHD) and host-versus-graft immune reactions. While the risk of GvHD from OTS T cells has been proved to be manageable in clinical studies, approaches to prevent immune rejection of OTS cells are at an earlier stage of development. We provide an overview of strategies to generate OTS cell therapies and mitigate alloreactivity-associated adverse events, with a focus on recent advances for preventing immune rejection.
引用
收藏
页码：261 / 272
页数：12
相关论文
共 50 条
  • [1] Off-the-shelf T-cell therapy
    Cooper, Laurence J. N.
    BLOOD, 2010, 116 (23) : 4741 - 4743
  • [2] T-Cell Engineering For "off-The-shelf" Adoptive Immunotherapy
    Poirot, Laurent
    Schiffer-Mannioui, Cecile
    Philip, Brian
    Derniame, Sophie
    Gouble, Agnes
    Chion-Sotinel, Isabelle
    Le Clerre, Diane
    Lemaire, Laetitia
    Grosse, Stephanie
    Cheung, Gordon
    Arnould, Sylvain
    Smith, Julianne
    Pule, Martin
    Scharenberg, Andrew
    BLOOD, 2013, 122 (21)
  • [3] Advances in Off-the-Shelf CAR T-Cell Therapy
    Benjamin, Reuben
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 155 - 157
  • [4] T-cell engineering for "off-the-shelf" adoptive immunotherapy
    Poirot, L.
    Mannioui, C. Schiffer
    Philips, B.
    Derniame, S.
    Gouble, A.
    Chion-Sotinel, I.
    Le Clerre, D.
    Lemaire, L.
    Grosse, S.
    Cheung, G.
    Arnould, S.
    Smith, J.
    Pule, M.
    Scharenberg, A.
    HUMAN GENE THERAPY, 2013, 24 (12) : A45 - A45
  • [5] Toward the development of true "off-the-shelf" synthetic T-cell immunotherapy
    Iriguchi, Shoichi
    Kaneko, Shin
    CANCER SCIENCE, 2019, 110 (01): : 16 - 22
  • [6] Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Zakrzewski, Johannes L.
    Suh, David
    Smith, Odette M.
    King, Christopher
    Goldberg, Gabrielle L.
    Jenq, Robert
    Holland, Amanda M.
    Grubin, Jeremy
    Lu, Sydney X.
    Cabrera-Perez, Javier
    Rizzuto, Gabrielle
    Sant'Angelo, Derek B.
    van den Brink, Marcel R. M.
    Markley, John C.
    Riviere, Isabelle
    Sadelain, Michel
    Zuniga-Pflucker, Juan Carlos
    BLOOD, 2007, 110 (11) : 178A - 178A
  • [7] Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies
    Poirot, Laurent
    Philip, Brian
    Schiffer-Mannioui, Cecile
    Le Clerre, Diane
    Chion-Sotinel, Isabelle
    Derniame, Sophie
    Potrel, Pierrick
    Bas, Cecile
    Lemaire, Laetitia
    Galetto, Roman
    Lebuhotel, Celine
    Eyquem, Justin
    Cheung, Gordon Weng-Kit
    Duclert, Aymeric
    Gouble, Agnes
    Arnould, Sylvain
    Peggs, Karl
    Pule, Martin
    Scharenberg, Andrew M.
    Smith, Julianne
    CANCER RESEARCH, 2015, 75 (18) : 3853 - 3864
  • [8] OFF-THE-SHELF TUMOR IMMUNOTHERAPY WITH GENETICALLY ENHANCED ALLOGENEIC T-CELL PRECURSORS
    Zakrzewski, J. L.
    Suh, D.
    Markley, J. C.
    Smith, O. M.
    King, C.
    Goldberg, G.
    Jenq, R.
    Holland, A. M.
    Grubin, J.
    Cabrera-Perez, J.
    Lu, S. X.
    Rizzuto, G.
    Sant'Angelo, D. B.
    Riviere, I
    Sadelain, M.
    Zuniga-Pflucker, J. C.
    van den Brink, M. R. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 126 - 126
  • [9] "Off-the-Shelf" CAR T-Cell Therapy Tested in Pediatric B-Cell Leukemia
    Larkin, Howard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (22): : 2201 - 2201
  • [10] OFF-THE-SHELF CAR T CELL IMMUNOTHERAPY FOR GLIOBLASTOMA
    Martins, P.
    D'Souza, R.
    Smith, C.
    Day, B.
    Khanna, R.
    CYTOTHERAPY, 2023, 25 (06) : S238 - S238
12345